Cilostazol /sᵻˈlɒstəzɒl/ is a quinolinone-derivative medication used in the alleviation of the symptom of intermittent claudication in individuals with peripheral vascular disease.
Triflusal
Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.
Picotamide
Picotamide is a platelet aggregation inhibitor.
Terbogrel
Terbogrel blocks thromboxanes and is expected to be useful in treating the vasoconstricting and platelet aggregating action of this compound.
Ditazole
Ditazole is a platelet aggregation inhibitor.
Cloricromen
Cloricromen is a platelet aggregation inhibitor.
Ramatroban
Ramatroban (INN) is a thromboxane receptor antagonist.
Terutroban
Terutroban is an antiplatelet agent developed by Servier Laboratories.
Aloxiprin
Aloxiprin (or aluminium acetylsalicylate) is a medical drug used for the treatment of pain and inflammation associated with muscular skeletal and joint disorders.
Dipyridamole
Dipyridamole (trademarked as Persantine) is a medication that inhibits blood clot formation when given chronically and causes blood vessel dilation when given at high doses over a short time.
Indobufen
Indobufen is a platelet aggregation inhibitor.
Clorindione
Clorindione is a vitamin K antagonist.
Carbasalate calcium
Carbasalate calcium is an analgesic, antipyretic, and anti-inflammatory drug, as well as a platelet aggregation inhibitor.